Skip to main content
SpringerLink
Log in

Steroid Derivatives

  • Chapter
New Neuromuscular Blocking Agents

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 79))

Abstract

The various hypotheses concerning the relationship between neuromuscular blocking activity and interonium structures make the study of almost rigid molecules of particular interest. The use of a fairly fixed steroid skeleton to which reactive side chains are attached (Alauddin and Martin-Smith 1962) was an important step forward in the search for useful curarizing drugs and resulted in a very powerful competitive acetylcholine antagonist, pancuronium (Buckett and Bonta 1966; Buckett et al. 1968; Savage et al. 1971). Reports on its use in human practice started with Baird and Reid (1967) and the drug is still the most widely utilized one. In spite of its general sucess, pancuronium is not yet the ideal curare-like agent because of its relatively long duration of action and of its multicausal cardiovascular stimulating property.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agoston S, Kersten UVW (1976) The pharmacokinetics of the steroid muscle relaxants. In: Spierdijk J, Feldman SA, Mattie H (eds) Anaesthesia and pharmacology. Williams and Wilkins, Baltimore

    Google Scholar 

  • Agoston S, Crul EJ, Kersten UW, Houwertjes MC, Scaf AHJ (1977) The relationship between disposition and duration of action of a congeneric series of steroidal neuromuscular blocking agents. Acta Anaesthesiol Scand 21:24–30

    Article  PubMed  CAS  Google Scholar 

  • Alauddin M, Martin-Smith M (1962) Biological activity in steroids possessing nitrogen atoms. Part I. Synthetic nitrogenous steroids. J Pharm Pharmacol 14:325–349

    Article  PubMed  CAS  Google Scholar 

  • Alauddin M, Caddy B, Lewis JJ, Martin-Smith M, Sugrue MF (1965) Non-depolarising neuromuscular blockade by 3α,17α-bis/quaternary ammonium/5α-androstanes. J Pharm Pharmacol 17:55–59

    Article  PubMed  CAS  Google Scholar 

  • Baird WLM, Reid AM (1967) The neuromuscular blocking properties of a new steroid compound, pancuronium bromide (a pilot study in man). Br J Anaesth 39:775–780

    Article  PubMed  CAS  Google Scholar 

  • Bamford DG, Biggs DF, Davis M, Parnell EW (1967) Neuromuscular blocking properties of stereoisomeric androstane-3,17-bisquaternary ammonium salts. Br J Pharmacol Chemother 30:194–202

    PubMed  CAS  Google Scholar 

  • Bamford DG, Biggs DF, Davis M, Parnell EW (1971) The neuromuscular blocking activity of some monoquaternary androstane derivatives. J Pharm Pharmacol 23:595–599

    Article  PubMed  CAS  Google Scholar 

  • Biró K, Kárpáti E (1981) The pharmacology of a new short acting nondepolarising muscle relaxant steroid (RGH-4201). Arzneimittelforsch 31:1918–1924

    PubMed  Google Scholar 

  • Blanpin O, Bretaudeau J (1961) Etude pharmacodynamique des sulfométhylates de triméthylfuntuminium et de triméthylfuntumidinium. CR Soc Biol (Paris) 155:878–883

    CAS  Google Scholar 

  • Bovet D (1972) Synthetic inhibitors of neuromuscular transmission. In: Cheymol J (ed) International encyclopedia of pharmacology and therapeutics, sect 14, vol 1. Neuromuscular blocking and stimulating agents. Pergamon, Oxford

    Google Scholar 

  • Buckett WR (1972) Aspects of the pharmacology of aminosteroids. In: Briggs MH, Christie G (eds) Advances in steroid biochemistry and pharmacology, vol 3. Academic, London

    Google Scholar 

  • Buckett WR (1975) Steroidal neuromuscular blocking agents. In: Harper NJ, Simmonds AB (eds) Advances in drug research, vol 10. Academic, London

    Google Scholar 

  • Buckett WR, Bonta IL (1966) Pharmacological studies with NA97 (2β,16β-dipiperidino-5α-androstane-3α17β-diol diacetate dimethobromide). Fed Proc 25:718

    Google Scholar 

  • Buckett WR, Marjoribanks CEB, Marwick FA, Morton MB (1968) The pharmacology of pancuronium bromide (Org NA97), a new potent steroidal neuromuscular blocking agent. Br J Pharmacol Chemother 32:671–682

    PubMed  CAS  Google Scholar 

  • Buckett WR, Hewett CL, Savage DS (1973) Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments. J Med Chem 16:1116–1124

    Article  PubMed  CAS  Google Scholar 

  • Busfield D, Child KJ, Clarke AJ, Davis B, Dodds MG (1968) Neuromuscular blocking activities of some steroidal mono and bis-quaternary ammonium compounds with special reference to NN′-dimethylconessine. Br J Pharmacol Chemother 32:609–623

    PubMed  CAS  Google Scholar 

  • Cavallito CJ, Gray AP (1960) Chemical nature and pharmacological actions of quaternary ammonium salts. Prog Drug Res 2:135–225

    CAS  Google Scholar 

  • Crul JF (1976) New muscle relaxants. In: Spierdijk J, Feldman SA, Mattie H (eds) Anaesthesia and pharmacology. Williams and Wilkins, Baltimore

    Google Scholar 

  • D’Hollander A, Delcroix C (1981) An analytical pharmacodynamic model for nondepolarising neuromuscular blocking agents. J Pharmacokinet Biopharm 9:27–40

    Article  PubMed  Google Scholar 

  • Durant NN, Marshall IG, Savage DS, Nelson DJ, Sleigh T, Carlyle IC (1979) The neuromuscular and autonomic blocking activities of pancuronium, Org NC45, and other pancuronium analogues in the cat. J Pharm Pharmacol 31:831–836

    Article  PubMed  CAS  Google Scholar 

  • Feldman SA (1976) Pharmacokinetics of the non-depolarizing muscle relaxants. In: Spierdijk J, Feldman SA, Mattie H (eds) Anaesthesia and pharmacology. Williams and Wilkins, Baltimore

    Google Scholar 

  • Feldman SA, Tyrell MF (1970) A new theory of the action of muscle relaxants. Br J Anaesth 42:91–92

    Article  PubMed  CAS  Google Scholar 

  • Gandiha A, Marshall IG, Paul D, Singh H (1974) Neuromuscular and other blocking actions of a new series of mono and bisquaternary aza steroids. J Pharm Pharmacol 26:871–877

    Article  PubMed  CAS  Google Scholar 

  • Gandiha A, Marshall IG, Paul D, Rodger IW, Scott W, Singh H (1975) Some actions of chandonium iodide, a new short-acting muscle relaxant, in anaesthetized cats and on isolated muscle preparations. Clin Exp Pharmacol Physiol 2:159–170

    Article  PubMed  CAS  Google Scholar 

  • Garcia DB, Brown RG, Delgado JN (1980) Synthesis, stereochemical analysis and neuromuscular blocking activity of selected E,E- and Z,Z-isomeric O-ethers of 4-androstene-3,17-dione dioximes. J Pharm Sci 69:995–999

    Article  PubMed  CAS  Google Scholar 

  • Hamed MI, El-Gholmy Z (1972) Quillaiate of choline iodide: a new monoquaternary neuromuscular blocking agent. Arzneimittelforsch 22:2133–2136

    PubMed  CAS  Google Scholar 

  • Hull CJ (1982) Pharmacodynamics of non-depolarizing neuromuscular blocking agents. Br J Anaesth 54:169–182

    Article  PubMed  CAS  Google Scholar 

  • Kárpáti E, Biró K (1980) Pharmacological study of a new competitive neuromuscular blocking steroid, pipecuronium bromide. Arzneimittelforsch 30:346–354

    PubMed  Google Scholar 

  • Kharkevich DA (1974) New curare-like agents. J Pharm Pharmacol 26:153–165

    Article  PubMed  CAS  Google Scholar 

  • Khuong Huu F, Pinto-Scognamiglio W (1964) Activité curarisante du dichlorure de 3ß-20αbistrimethylammonium 5α-prégnane (malouétine) et de ses stéréoisomeres. Arch Int Pharmacodyn 147:209–219

    Google Scholar 

  • Lewis JJ, Martin-Smith M, Muir TC, Ross HH (1967) Steroidal monoquaternary ammonium salts with nondepolarising neuromuscular blocking activity. J Pharm Pharmacol 19:502–508

    Article  PubMed  CAS  Google Scholar 

  • Loomis TA (1963) Neuromuscular effects of piperidylmethyl-androstane-diol. Arch Int Pharmacodyn 141:412–422

    CAS  Google Scholar 

  • Marshall IG (1973) The effects of three short-acting neuromuscular blocking agents on fast- and slow-contracting muscles of the cat. Eur J Pharmacol 21:299–304

    Article  PubMed  CAS  Google Scholar 

  • Marshall IG, Martin-Smith M (1972) Ganglion-blocking activity of bisquaternary ammonium salts derived from 3α,12α-diamino-5β-cholane and 3α,12α-diamino-24-nor-5β-cholane. Eur J Pharmacol 17:39–43

    Article  PubMed  CAS  Google Scholar 

  • Marshall IG, Paul D, Singh H (1973) The neuromuscular and other blocking actions of 4,17a-dimethyl-4,17a-diaza-D-homo-5α-androstane dimethoiodide (HS 342) in the anaesthetized cat. Eur J Pharmacol 22:129–134

    Article  PubMed  CAS  Google Scholar 

  • Marshall IG, Harvey AL, Singh H, Bhardway TR, Paul D (1981) The neuromuscular and autonomic blocking effects of azasteroids containing choline or acetylcholine fragments. J Pharm Pharmacol 33:451–457

    Article  PubMed  CAS  Google Scholar 

  • Martin-Smith M (1971) Rational elements in the development of superior neuromuscular blocking agents. In: Ariens EJ (ed) Drug design, vol 2. Acedemic, New York

    Google Scholar 

  • Quévauviller MA, Lainé MF (1960) Sur la toxicité et le pouvoir curarisant du chlorure de malouétine. Ann Pharm Fr 18:678–680

    PubMed  Google Scholar 

  • Roquet F, Harring J, Godard F, Aurousseau M (1971) Communication to the European medical chemistry congress, Lyon

    Google Scholar 

  • Savage DS, Cameron AF, Ferguson G, Hannaway C, Mackay IR (1971) Molecular structure of pancuronium bromide (3α,17β-diacetoxy-2β,16β-dipiperidino-5α-androstane dimethobromide), a neuromuscular blocking agent. Crystal and molecular structure of the water: methylene chloride solvate. J Chem Soc C:410–415

    Google Scholar 

  • Sugrue MF, Duff N, McIndewar I (1975) On the pharmacology of Org 6368 (2β,16β-dipiperidino-5α-androstan-3α-ol acetate dimethobromide), a new steroidal neuromuscular blocking agent. J Pharm Pharmacol 27:721–727

    Article  PubMed  CAS  Google Scholar 

  • Teerapong P, Marshall IG, Harvey AL, Singh H, Paul D, Bhardwaj TR, Ahuja NK (1979) The effects of dihydrochandonium and other chandonium analogues on neuromuscular and autonomic transmission. J Pharm Pharmacol 31:521–528

    PubMed  CAS  Google Scholar 

  • Tuba Z, Marsai M, Görög S, Biró K, Kárpáti E, Szporny L (1981) Procedure for the synthesis of new 3-amino-17a-aza-D-homo androstan derivatives, its acid addition and quaternary salts (in Hungarian). Pat Hung 175 287

    Google Scholar 

Download references

Authors
  1. M. Riesz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Kárpáti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Szporny
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacology, Academy of Medical Sciences First Medical Institute, 2/6 Pirogovskaya Street, Moscow, II9435, USSR

    Dimitry A. Kharkevich M.D., D. Sc. (Professor and Chairman of the Department of Pharmacology Academician of the USSR) (Professor and Chairman of the Department of Pharmacology Academician of the USSR)

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Riesz, M., Kárpáti, E., Szporny, L. (1986). Steroid Derivatives. In: Kharkevich, D.A. (eds) New Neuromuscular Blocking Agents. Handbook of Experimental Pharmacology, vol 79. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70682-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70682-0_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70684-4

  • Online ISBN: 978-3-642-70682-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation